Agent myeloma has a new weapon from (ch1)Q

In this issue of Blood, Trasanidis et al(1) use a multiomics analysis to define a novel transcriptional network that is important in driving the poor outcomes associated with amplification of chromosome 1q in multiple myeloma.

Automated summary

In this study, the authors use multiomics analysis to identify a novel transcriptional network that is crucial for the poor outcomes associated with chromosome 1q amplification in multiple myeloma.